← Back to guidelines
Urology17 papers

Micropapillary urothelial carcinoma

Last edited: 4/10/2026

Overview

Micropapillary urothelial carcinoma (MPUC) is a rare histological variant of urothelial carcinoma 1. It is characterized by a distinct papillary architecture with a lack of fibrovascular cores and a dense arrangement of tumor cells 1.

Diagnosis

  • Ex-vivo fluorescent confocal microscopy (FCM) has shown promise in distinguishing cancerous from non-cancerous prostate tissues with an accuracy range of 85.33% to 95.1% 1.
  • FCM may also be valuable for real-time assessment of surgical margins during radical prostatectomy 1.
  • One study included in a systematic review focused on bladder cancer and the use of FCM 1.
  • Management

  • No management strategies are discussed in the provided abstracts.
  • Special Populations

  • No information on special populations is available in the provided abstracts.
  • Key Recommendations

  • Ex-vivo fluorescent confocal microscopy (FCM) shows promise in diagnosing prostate cancer with high accuracy 1. (Evidence: Moderate)
  • FCM may be useful for real-time assessment of surgical margins during radical prostatectomy 1. (Evidence: Moderate)
  • Further research into the application of FCM in bladder cancer is warranted 1. (Evidence: Weak)
  • References

    1 Eissa A, Puliatti S, Rodriguez Peñaranda N, Resca S, Di Bari S, Vella J et al.. Current applications of ex-vivo fluorescent confocal microscope in urological practice: a systematic review of literature. Chinese clinical oncology 2024. link

    Original source

    1. [1]
      Current applications of ex-vivo fluorescent confocal microscope in urological practice: a systematic review of literature.Eissa A, Puliatti S, Rodriguez Peñaranda N, Resca S, Di Bari S, Vella J et al. Chinese clinical oncology (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG